These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 2116668

  • 1. Mitomycin, ifosfamide, and mesna in the treatment of lung cancer.
    Dorr RT.
    Semin Oncol; 1990 Aug; 17(4 Suppl 7):2-5. PubMed ID: 2116668
    [Abstract] [Full Text] [Related]

  • 2. Combination chemotherapy with ifosfamide, mitomycin, and cisplatin in advanced non-small cell lung cancer.
    Girón CG, Ordónez A, Jalón JI, Barón MG.
    Cancer Treat Rep; 1987 Sep; 71(9):851-3. PubMed ID: 3040245
    [Abstract] [Full Text] [Related]

  • 3. An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer.
    Depierre A, Milleron B, Lebeau B, Moro D, Chastang C, Jacoulet P, Paillot N, Quoix E, Janicot H, Lombard JN.
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):16-9. PubMed ID: 8209272
    [Abstract] [Full Text] [Related]

  • 4. Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
    Matthiessen W, Stempinski E, Göbel D, Thalmann U.
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():121-3. PubMed ID: 6414688
    [No Abstract] [Full Text] [Related]

  • 5. [Polychemotherapy of non-small cell bronchial cancer with mitomycin C, ifosfamide and vindesine].
    Laumen R, Jungbluth H, von Pawel J, Häussinger K, Otto M, Krieger H.
    Pneumologie; 1990 Feb; 44 Suppl 1():590. PubMed ID: 2164206
    [Abstract] [Full Text] [Related]

  • 6. Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer.
    Soh LT, Tan EH, Ang PT.
    Singapore Med J; 1998 Aug; 39(8):357-8. PubMed ID: 9844496
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
    Sutton GP, Blessing JA, Photopulos G, Berman ML, Homesley HD.
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
    [Abstract] [Full Text] [Related]

  • 13. Anticipated administration of GM-CSF in the treatment of non small cell lung cancer.
    Erkisi M, Erkurt E, Zeren H, Tunali C, Kocabas A, Burgut R.
    J Exp Clin Cancer Res; 2001 Sep; 20(3):345-9. PubMed ID: 11718213
    [Abstract] [Full Text] [Related]

  • 14. High-dose ifosfamide and mesna in advanced breast cancer. A phase II study.
    Sanchiz F, Milla A.
    Cancer Chemother Pharmacol; 1990 Sep; 26 Suppl():S91-2. PubMed ID: 2112057
    [Abstract] [Full Text] [Related]

  • 15. Ifosfamide in non-small cell lung cancer.
    Johnson DH.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):7-10. PubMed ID: 8677453
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.